Allo-HSCT as First-line Consolidation in High-risk PTCL

Clinical trial NCT03672084 · UNKNOWN

Trial details

NCT number: NCT03672084
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

T Cell Lymphoma

Start date: 2019-01-01
Primary completion: 2023-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.